The galactose elimination capacity test: A study of the technique based on the analysis of 868 measurements

American Journal of Gastroenterology

Volumn 91, Issue 5, 1996, Pages 991-996

  Fabbri, Andrea ^a   Bianchi, Giampaolo ^a   Motta, Elisabetta ^a   Brizi, Mara ^a   Zoli, Marco ^a   Marchesini, Giulio ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CARBOHYDRATE METABOLISM; DRUG ELIMINATION; FEMALE; HUMAN; LABORATORY TEST; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METABOLIC REGULATION; PRIORITY JOURNAL; TECHNIQUE;

ADOLESCENT; ADULT; AGED; GALACTOSE; GALACTOSEMIAS; HUMANS; LIVER FUNCTION TESTS; MIDDLE AGED; OSMOLAR CONCENTRATION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0029919996     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Merkel C, Gatta A, Zoli M, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis: Comparison with the Pugh score. Dig Dis Sci 1991;36:1197-203.
2. Tygstrup N, Vilstrup H. Functional evaluation of the hepatocyte. In: Beker S, ed. Diagnostic procedure in the evaluation of hepatic diseases, vol 7. New York: Alan R. Liss, 1983:17-41.
3. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest 1966;92(suppl): 118-25.
4. Tygstrup N, Winkler K. Kinetics of galactose elimination. Acta Physiol Scand 1954;32:354-62.
5. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60: 646-9.
6. Bernstein LM, Wheeler JX, Bond EE, et al. The blood galactose disappearance curve as a test of liver function. Gastroenterology 1960; 39:293-300.
7. Snedecor GW, Cochran WG. Statistical methods, 7th ed. Ames, Iowa: The IOWA State University Press, 1980.
8. Colton T. Statistics in medicine. Boston: Little, Brown, 1974.
9. Henderson JM, Kutner MH, Bain RP. First-order clearance of plasma galactose: The effect of liver disease. Gastroenterology 1982;83:1090-5.
10. Keiding S. Galactose clearance measurements and liver blood flow. Gastroenterology 1988;94:477-81.
11. Gremse DA A-Kader HH, Schroder TJ, et al. Assessment of lidocaine metabolite formation as a quantitative liver function test in children. Hepatology 1990;12:565-9.
12. Arrigoni A, Gindro T, Aimo G, et al. Monoethylglycine xylidide test: A prognostic indicator of survival in cirrhosis. Hepatology 1994;20: 383-7.
13. Marchesini G, Fabbri A, Bugianesi E, et al. Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity. Liver 1990;10:65-71.
14. Vilstrup H, Iversen J, Tygstrup N. Glucoregulation in acute liver failure. Eur J Clin Invest 1986;16:193-7.
15. Tygstrup N. Determination of the hepatic galactose elimination capacity after a single intravenous injection in man. The reproducibility and the influence of uneven distribution. Acta Physiol Scand 1963;58:162-72.
16. Tygstrup N. The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med Scand 1964;175: 281-9.
17. Bianchi GP, Marchesini G, Vilstrup H, et al. Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with liver cirrhosis. A simplified method. Hepatology 1991;13:460-6.
18. Vinel JP, Caucanas JP, Cales P, et al. Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis. J Hepatol 1988;7:186-92.
19. Døssing M, Poulsen HE, Andreasen PB, et al. A simple method for determination of antipyrine clearance. Clin Pharmacol Ther 1982;32: 392-6.
20. Oellerich M, Burdelski M, Lautz H-U, et al. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 1991;14: 1029-34.